Celanese Q2 adjusted EPS beats estimates, sales meet expectations
CE•Drivers and cost savings
The company said higher prices and increased volumes across both business segments helped lift sales. Celanese also cited continued momentum in medical and electronics as contributing to results.
It said it completed cost-saving initiatives, including facility closures and manufacturing network optimization, that are expected to deliver more than $50 million in annualized fixed-cost savings.
Outlook and analyst context
Celanese expects third-quarter adjusted EPS of about $1.35 to $1.75 and maintained its full-year adjusted EPS guidance of about $6.00.
The company also expects 2026 free cash flow of $700 million to $800 million.
Analyst coverage on the shares currently averages buy, with a median 12-month price target of $68.00, about 54.9% above the August 3 closing price of $43.89. The stock recently traded at 7 times next-12-month earnings, down from a P/E of 12 three months ago.
Q2 results beat EPS estimates, sales met expectations
Celanese said second-quarter sales were $2.75 billion, meeting analyst expectations and rising . Adjusted earnings per share for the quarter were , above the analyst consensus.
